Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.325 AUD | -7.14% | -7.14% | -50.76% |
Apr. 23 | Australian Shares Rise on Business Activity Growth; Osteopore Soars 127% | MT |
Apr. 23 | Osteopore Commences In-Human Clinical Trials for Knee Preservation; Shares Surge 194% | MT |
Sales 2022 | 1.69M 1.25M 1.89M | Sales 2023 | 2.22M 1.64M 2.48M | Capitalization | 6.82M 5.04M 7.61M |
---|---|---|---|---|---|
Net income 2022 | -4M -2.96M -4.47M | Net income 2023 | -4M -2.96M -4.47M | EV / Sales 2022 | 9.64 x |
Net cash position 2022 | 1.27M 942K 1.42M | Net cash position 2023 | 64.06K 47.39K 71.54K | EV / Sales 2023 | 3.05 x |
P/E ratio 2022 |
-4.42
x | P/E ratio 2023 |
-1.29
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 96.4% |
1 day | -7.14% | ||
1 week | -7.14% | ||
Current month | -7.14% | ||
1 month | +170.83% | ||
3 months | -42.98% | ||
6 months | -55.78% | ||
Current year | -50.76% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Jing Lim
CEO | Chief Executive Officer | - | 14-11-30 |
Ning Voon Shu
AUD | Comptroller/Controller/Auditor | - | - |
Kellie Davis
SEC | Corporate Secretary | - | 23-01-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kei Wei Leong
CHM | Chairman | 49 | 21-07-31 |
Michael Keenan
BRD | Director/Board Member | - | 23-07-17 |
Swee Hin Teoh
BRD | Director/Board Member | - | 19-06-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 0.325 | -7.14% | 59 101 |
24-05-06 | 0.35 | -6.67% | 36,356 |
24-05-03 | 0.375 | +25.00% | 123,481 |
24-05-02 | 0.3 | -9.09% | 307,946 |
24-05-01 | 0.33 | -5.71% | 21,011 |
Delayed Quote Australian S.E., May 06, 2024 at 10:11 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-50.76% | 2.56M | |
-4.02% | 184B | |
-0.75% | 108B | |
-2.97% | 67.82B | |
+4.48% | 51.05B | |
+9.09% | 44.67B | |
+3.74% | 41.78B | |
+3.12% | 26.78B | |
+4.10% | 26.59B | |
+15.32% | 25.86B |
- Stock Market
- Equities
- OSX Stock